NCT05954962 - Efficacy of Micronized Natural Progesterone Vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

December 23, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

August 30, 2025

Conditions

IVF

Interventions

DRUG

Progesterone 200 MG

"The patients in the study group will administer oral natural micronized progesterone capsules from day 1 of ovarian stimulation instead of antagonist (ganirelix) subcutaneaous injections from day 5-6 of stimulation."

DRUG

Ganirelix Acetate

The patients in the control group will administer subcutaneaous injections of ganirelix from day 5-6 of stimulation as per currently used protocol.

Trial Locations (1)

03206

RECRUITING

Instituto Bernabeu, Elche